Literature DB >> 30431439

Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression.

Na Liu1, Jing Luo1, Dong Kuang2,3, Sanpeng Xu2,3, Yaqi Duan2,3, Yu Xia1, Zhengping Wei1, Xiuxiu Xie1, Bingjiao Yin1, Fang Chen1, Shunqun Luo4, Huicheng Liu1, Jing Wang1, Kan Jiang5, Feili Gong1, Zhao-Hui Tang6, Xiang Cheng7, Huabin Li8, Zhuoya Li1, Arian Laurence9, Guoping Wang2,3, Xiang-Ping Yang1.   

Abstract

Macrophages perform key functions in tissue homeostasis that are influenced by the local tissue environment. Within the tumor microenvironment, tumor-associated macrophages can be altered to acquire properties that enhance tumor growth. Here, we found that lactate, a metabolite found in high concentration within the anaerobic tumor environment, activated mTORC1 that subsequently suppressed TFEB-mediated expression of the macrophage-specific vacuolar ATPase subunit ATP6V0d2. Atp6v0d2-/- mice were more susceptible to tumor growth, with enhanced HIF-2α-mediated VEGF production in macrophages that display a more protumoral phenotype. We found that ATP6V0d2 targeted HIF-2α but not HIF-1α for lysosome-mediated degradation. Blockade of HIF-2α transcriptional activity reversed the susceptibility of Atp6v0d2-/- mice to tumor development. Furthermore, in a cohort of patients with lung adenocarcinoma, expression of ATP6V0d2 and HIF-2α was positively and negatively correlated with survival, respectively, suggesting a critical role of the macrophage lactate/ATP6V0d2/HIF-2α axis in maintaining tumor growth in human patients. Together, our results highlight the ability of tumor cells to modify the function of tumor-infiltrating macrophages to optimize the microenvironment for tumor growth.

Entities:  

Keywords:  Immunology; Lysosomes; Macrophages; Oncology

Mesh:

Substances:

Year:  2019        PMID: 30431439      PMCID: PMC6355226          DOI: 10.1172/JCI123027

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

4.  Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.

Authors:  Russell D Leek; Kate L Talks; Francesco Pezzella; Helen Turley; Leticia Campo; Nicholas S Brown; Roy Bicknell; Marian Taylor; Kevin C Gatter; Adrian L Harris
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

5.  A lactate-induced response to hypoxia.

Authors:  Dong Chul Lee; Hyun Ahm Sohn; Zee-Yong Park; Sangho Oh; Yun Kyung Kang; Kyoung-Min Lee; Minho Kang; Ye Jin Jang; Suk-Jin Yang; Young Ki Hong; Hanmi Noh; Jung-Ae Kim; Dong Joon Kim; Kwang-Hee Bae; Dong Min Kim; Sang J Chung; Hyang Sook Yoo; Dae-Yeul Yu; Kyung Chan Park; Young Il Yeom
Journal:  Cell       Date:  2015-04-16       Impact factor: 41.582

6.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

Authors:  Linda Holmquist-Mengelbier; Erik Fredlund; Tobias Löfstedt; Rosa Noguera; Samuel Navarro; Helén Nilsson; Alexander Pietras; Johan Vallon-Christersson; Ake Borg; Katarina Gradin; Lorenz Poellinger; Sven Påhlman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

Review 7.  The updated biology of hypoxia-inducible factor.

Authors:  Samantha N Greer; Julie L Metcalf; Yi Wang; Michael Ohh
Journal:  EMBO J       Date:  2012-05-04       Impact factor: 11.598

8.  Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression.

Authors:  Maimon E Hubbi; Daniele M Gilkes; Hongxia Hu; Ishrat Ahmed; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

9.  Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.

Authors:  X-D Liu; J Yao; D N Tripathi; Z Ding; Y Xu; M Sun; J Zhang; S Bai; P German; A Hoang; L Zhou; D Jonasch; X Zhang; C J Conti; E Efstathiou; N M Tannir; N T Eissa; G B Mills; C L Walker; E Jonasch
Journal:  Oncogene       Date:  2014-07-07       Impact factor: 9.867

10.  Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.

Authors:  Elizabeth Allen; Pascal Miéville; Carmen M Warren; Sadegh Saghafinia; Leanne Li; Mei-Wen Peng; Douglas Hanahan
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

View more
  45 in total

Review 1.  Advances in Glycolysis Metabolism of Atherosclerosis.

Authors:  Ruhan Xu; Wei Yuan; Zhongqun Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-09-06       Impact factor: 3.216

Review 2.  Tumor Microenvironment: Lactic Acid Promotes Tumor Development.

Authors:  Yuting Gao; Hao Zhou; Gege Liu; Junlu Wu; Yi Yuan; Anquan Shang
Journal:  J Immunol Res       Date:  2022-06-12       Impact factor: 4.493

3.  A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma.

Authors:  Xing Jin; Zhengyang Hu; Qihai Sui; Mengnan Zhao; Jiaqi Liang; Zhenyu Liao; Yuansheng Zheng; Hao Wang; Yu Shi
Journal:  J Immunol Res       Date:  2022-07-01       Impact factor: 4.493

Review 4.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

Review 5.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

Review 6.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

Review 7.  Lactate shuttle: from substance exchange to regulatory mechanism.

Authors:  Xingchen Wang; He Liu; Yingqian Ni; Peibo Shen; Xiuzhen Han
Journal:  Hum Cell       Date:  2021-10-04       Impact factor: 4.174

Review 8.  Integration of transcriptional and metabolic control in macrophage activation.

Authors:  Gioacchino Natoli; Francesco Pileri; Francesco Gualdrini; Serena Ghisletti
Journal:  EMBO Rep       Date:  2021-07-30       Impact factor: 9.071

Review 9.  Lactylation: a Passing Fad or the Future of Posttranslational Modification.

Authors:  Qi Xin; Hai Wang; Qinglin Li; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Inflammation       Date:  2022-02-27       Impact factor: 4.657

10.  Splicing factor SRSF6 mediates pleural fibrosis.

Authors:  Li-Mei Liang; Liang Xiong; Pei-Pei Cheng; Shuai-Jun Chen; Xiao Feng; Ya-Ya Zhou; Qian Niu; Meng Wang; Qianlan Chen; Lin-Jie Song; Fan Yu; Xin-Liang He; Fei Xiang; Xiaorong Wang; Hong Ye; Wan-Li Ma
Journal:  JCI Insight       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.